Niramay Medical Foundation & Research Centre Private Limited
Founded: 2000
Status: Active
Designation: Director
Ajinkya Deshpande Ashok - Profile
Ajinkya Deshpande Ashok, Director and Designated Partner, with 4 companies.
About
Ajinkya Deshpande Ashok
Ajinkya Deshpande Ashok has 12 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Niramay Medical Foundation & Research Centre Private Limited and Anagram Quantitative Technologies Llp. Formerly with 1 company, such as Fractal Media Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
Current Companies
3
Past Companies
1
Total Affiliations
4
Oldest Company Age
25
Companies Associated with Ajinkya Deshpande Ashok
Current Companies
Anagram Quantitative Technologies Llp
Founded: 2015
Status: Active
Designation: Designated Partner
Lacard Goods And Services (Opc) Private Limited
Founded: 2024
Status: Active
Designation: Director
Previous Companies
Fractal Media Private Limited
Founded: 2016
Status: Strike Off
Designation: Director
Explore Director's current and past company associations— Uncover their professional journey today!
Frequently Asked Questions
Who is Ajinkya Deshpande Ashok?
Ajinkya Deshpande Ashok has 12 years in corporate governance. Holds Director and Designated Partner roles. Currently with 3 companies, including Niramay Medical Foundation & Research Centre Private Limited and Anagram Quantitative Technologies Llp. Formerly with 1 company, such as Fractal Media Private Limited. Engaged in General Business, Technology. Contributes to corporate operations.
What is Ajinkya Deshpande Ashok's role in current companies?
Ajinkya Deshpande Ashok is associated with 3 companies as Director and Designated Partner.
What industries does Ajinkya Deshpande Ashok specialize in?
Ajinkya Deshpande Ashok has expertise in General Business, Technology.
How many years of experience does Ajinkya Deshpande Ashok have?
Ajinkya Deshpande Ashok has 12 years in corporate governance.